Keywords: gsk, prepandrix, approved, ec, first, european, pre-pandemic

GSK's Prepandrix approved by EC, first European pre-pandemic flu vacc

Article | 26 May 2008

Print This

The European Commission has approved UK drug major GlaxoSmithKline's H5N1 adjuvanted vaccine, Prepandrix, making it the first company to ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in